Literature DB >> 22098828

Gastric cancer: endoscopic diagnosis and staging.

Rami El Abiad1, Henning Gerke.   

Abstract

Gastric cancer is common and is a cause of severe morbidity and mortality. Early diagnosis can improve the chances of cure and prolong survival because prognosis is inversely related to the disease stage. Endoscopy plays an important role in diagnosis. Emerging adjunct technologies such as image-enhanced endoscopy and magnification endoscopy aid in early cancer detection. Endoscopic ultrasonography is an additional useful tool for preoperative staging. Endoscopy for screening, except for high-risk patients, and outside areas of high prevalence, remains controversial.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22098828     DOI: 10.1016/j.soc.2011.09.002

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  10 in total

Review 1.  Is endoscopic ultrasonography still the modality of choice in preoperative staging of gastric cancer?

Authors:  Sung Wook Hwang; Dong Ho Lee
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

2.  Introduction of plasmids into gastric cancer cells by endoscopic ultrasound.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Yasufumi Motoyoshi; Takao Sugiyama; Shigenori Yamamoto; Naoki Ishige
Journal:  Oncol Lett       Date:  2017-03-10       Impact factor: 2.967

3.  Lower serum folate is associated with development and invasiveness of gastric cancer.

Authors:  Teng-Yu Lee; En-Pei Chiang; Yin-Ting Shih; Hsien-Yuan Lane; Jaw-Town Lin; Chun-Ying Wu
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

4.  Gastric intestinal metaplasia and early gastric cancer in the west: a changing paradigm.

Authors:  Justin M Gomez; Andrew Y Wang
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-06

5.  Plasma miR-940 may serve as a novel biomarker for gastric cancer.

Authors:  Xin Liu; Ava Kwong; Alan Sihoe; Kent-Man Chu
Journal:  Tumour Biol       Date:  2015-10-11

6.  The Tumor Suppressor Roles of miR-433 and miR-127 in Gastric Cancer.

Authors:  Li-Hua Guo; Hui Li; Fang Wang; Jia Yu; Jin-Sheng He
Journal:  Int J Mol Sci       Date:  2013-07-08       Impact factor: 5.923

7.  Clinical significance and diagnostic value of serum CEA, CA19-9 and CA72-4 in patients with gastric cancer.

Authors:  Yao Liang; Wei Wang; Cheng Fang; Seeruttun Sharvesh Raj; Wan-Ming Hu; Qi-Wen Li; Zhi-Wei Zhou
Journal:  Oncotarget       Date:  2016-08-02

8.  Circulating Exosomal Gastric Cancer-Associated Long Noncoding RNA1 as a Biomarker for Early Detection and Monitoring Progression of Gastric Cancer: A Multiphase Study.

Authors:  Xin Guo; Xiaohui Lv; Yi Ru; Fuxing Zhou; Ning Wang; Hongqing Xi; Kecheng Zhang; Jiyang Li; Rongyan Chang; Tianyu Xie; Xinxin Wang; Baohai Li; Yong Chen; Yanling Yang; Lubin Chen; Lin Chen
Journal:  JAMA Surg       Date:  2020-07-01       Impact factor: 14.766

Review 9.  Precision medicine in gastric cancer.

Authors:  Patrizia Bonelli; Antonella Borrelli; Franca Maria Tuccillo; Lucrezia Silvestro; Raffaele Palaia; Franco Maria Buonaguro
Journal:  World J Gastrointest Oncol       Date:  2019-10-15

10.  MEF2A-mediated lncRNA HCP5 Inhibits Gastric Cancer Progression via MiR-106b-5p/p21 Axis.

Authors:  Weiwei Chen; Kundong Zhang; Yuhan Yang; Zengya Guo; Xiaofeng Wang; Buwei Teng; Qian Zhao; Chen Huang; Zhengjun Qiu
Journal:  Int J Biol Sci       Date:  2021-01-16       Impact factor: 6.580

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.